Chronic Lymphoblastic Leukemia
2 clinical trials · Condition
◉ Watch Chronic Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies (NCT04796688) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-03-10 |
| γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) (NCT04028440) | Institute of Hematology & Blood Diseases Hospital, China | 2019-10-01 |
Track Chronic Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.